Hikma Pharmaceuticals to Invest $1B in U.S. Manufacturing & R&D Capabilities
Hikma has operated in the US since 1991 and has spent more than $4 billion over the past 15 years to build, enhance and expand its US-based R&D and manufacturing capabilities and now has annual domestic capacity to produce more than 12 billion finished doses of essential medicines. Over this period, Hikma has provided patients with access to a wide range of generic medicines at a lower cost than branded products.
The new phase of investment represents the Company's latest efforts to increase the volume of essential medicines it develops and produces across its R&D and manufacturing sites in Columbus and Cleveland, Ohio and in Cherry Hill and Dayton, New Jersey. This next phase of expansion will help to strengthen Hikma's portfolio of more than 800 medicines and increase the Company's US-based capacity to produce large volumes of high-quality and affordable medicines for American hospitals, providers and patients.
'We are proud to continue our ongoing investments in US manufacturing and R&D to better serve the needs of American patients,' said Dr. Hafrun Fridriksdottir, President, Hikma Rx. 'Hikma and our 2,300 dedicated US people are committed to supporting healthier communities nationwide by providing Americans with a steady and reliable supply of domestically produced quality medicines.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Ammon
5 hours ago
- Ammon
Jordan's trade balance with US records JD171m in first four months of 2025
Ammon News - Jordan's trade balance with the United States recorded a surplus of JD171 million in the first four months of 2025, according to foreign trade data released by the Department of Statistics. National exports to the US rose by 6.9 percent, reaching JD701 million, compared to JD656 million in the same period last year. Imports from the US market totaled JD530 million, up by 31.2 percent from JD404 million last year, the figures showed. The overall volume of trade exchange between the two countries grew to JD1.231 billion in the first third of 2025, compared to JD1.060 billion for the same period last year, it said. National exports to the US accounted for 25.5 percent of Jordan's total exports in the reporting period. The bulk of Jordanian exports to the US included clothing and related accessories, fertilizers and chemical products, pharmaceuticals, jewelry, food and animal products, information technology services, and engineering industries. Meanwhile, Jordan's key imports from the US market were metals, transportation equipment, machinery, electrical appliances, grains, chemicals, medical devices, food, animal products, furniture, iron products, used clothing, vegetable oils and fats, and wood.
Ammon
5 hours ago
- Ammon
Amman Stock Exchange rises 1.17%
Ammon News - The Amman Stock Exchange (ASE) closed Wednesday's trading session with a 1.17 percent increase, reaching 2,807 points. According to ASE data, the volume of traded shares stood at approximately 4 million, with a total turnover of about JD14.5 million generated through 3,688 transactions. A comparison of closing prices showed that share prices increased for 35 companies, declined for 27, and remained unchanged for 30 others. Petra
Ammon
7 hours ago
- Ammon
Grant worth $7.5 million to support Jordan Reform Management Project
Ammon News - The Cabinet, in its session held Wednesday, headed by Prime Minister Dr. Jafar Hassan, approved a €5.5 million cooperation agreement between the Ministry of Health and the Spanish Agency for International Development Cooperation to improve access to non-communicable disease care in Zarqa Governorate. The four-year grant will fund the rehabilitation of health centers, procurement of medical and IT equipment, and support public health awareness campaigns. Additionally, the Cabinet approved a second additional financing agreement worth $7.5 million with the World Bank to support the Jordan Reform Management Project. The funding will help strengthen implementation of economic and structural reforms, improve the national investment registry, and enhance the public-private partnership framework.
